Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study

被引：0
|
作者：
Orlandi-Jorquera, L
Orlandi, F
Galaz, P
Gamargo, C
Salman, P
Yanez, M
机构：
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
486
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [21] Phase II study of Gemcitabine in combination with cisplatin and ifosfamide in advanced non-small cell lung cancer
    Mohedano, N
    Medina, MB
    Sanchez, P
    Jaen, A
    Gonzalez, E
    Porras, I
    Fernandez, M
    Lozano, A
    ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [22] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Manegold, C.
    Digumarti, R.
    Zukin, M.
    de Marinis, F.
    Mellerngaard, A.
    Gandara, D.
    Simms, L.
    Kaiser, C.
    Blatter, J.
    Gatzemeier, U.
    EJC SUPPLEMENTS, 2007, 5 (06): : 9 - 9
  • [23] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Purvish, Parikh
    von Pawel, Joachim
    Biesma, Bonna
    Vansteenkiste, Johan
    Manegold, Christian
    Simms, Lorinda
    Posther, Sugarman Katherine
    Obasaju, Coleman
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S306
  • [24] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [25] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
  • [26] Phase II study of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)
    Firvida, JL
    Rodriguez, R
    Sabin, P
    Castellanos, J
    Mata, JG
    Salgado, M
    Vazquez, S
    Lazaro, M
    Delgado, FM
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [27] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
  • [28] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [29] Phase mi study of Gemcitabine plus vinorelbine in non-small cell lung cancer (NSCLC)
    Puertas, J
    Esteban, E
    Fra, J
    Liano, JLG
    Vieitez, JM
    Estrada, E
    Palacio, I
    Muniz, I
    Buesa, JM
    Lacave, AJ
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [30] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
12345